newsfilter
← Latest News
Business Wire·

Sesen Bio Strengthens Medical Team

Sesen Bio (NASDAQ:SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, today announced the strengthening of its medical team with the hiring of Dominika Kowalski as Senior Direct